Table 1.
Demographic characteristics of participants (N = 136).
| Variable | Category | n (%) |
|---|---|---|
| Gender | Male | 84 (61.8) |
| Female | 52 (38.2) | |
| Age | 15–19 years | 79 (58.1) |
| 20–24 years | 57 (41.9) | |
| Age at diagnosisa | ≤ 6 years | 36 (26.7) |
| 7–12 years | 49 (36.3) | |
| 13–15 years | 32 (23.7) | |
| 16–18 years | 18 (13.3) | |
| Duration after treatmentb | ≤ 6 months–< 1 year | 12 (9.0) |
| ≤ 1 year–< 2 years | 11 (8.3) | |
| ≤ 2 years–< 5 years | 36 (27.1) | |
| ≥ 5 years | 74 (55.6) | |
| Diagnosis | Leukemia | 67 (49.3) |
| Lymphoma | 28 (20.6) | |
| Brain tumor | 16 (11.8) | |
| Solid tumor/Other | 25 (18.4) | |
| Treatmenta | Only chemotherapy | 31 (22.8) |
| Combined therapy that included chemotherapy | 38 (27.9) | |
| Combined therapy that included transplantation | 64 (47.1) | |
| Other | 2 (1.5) | |
| Duration of academic interruption due to disease and/or treatmenta | None | 30 (22.2) |
| ≤ 1 month–< 1 year | 14 (10.4) | |
| ≤ 1 year–< 2 years | 49 (36.3) | |
| ≥ 2 years | 42 (31.1) | |
| Currently attending school | Yes | 108 (79.4) |
| No | 28 (20.6) |
M, mean; SD, standard deviation.
a
With missing value (n = 1).
b
With missing value (n = 3).